Principal Scientist / Senior Scientist, Analytical Development

San Diego, CA, United States
Feb 02, 2021
Required Education
Position Type
Full time
Fate Therapeutics is seeking a highly-motivated individual with extensive assay development expertise to join the analytical development team. The successful candidate will be responsible for developing analytical methods in support of the development of novel, off-the-shelf, engineered iPSC-derived NK and T cell therapies. Operating in a cross-functional and dynamic environment, the individual will work closely with Quality Control, Process Development, Manufacturing Sciences and Technology, Product Development, Regulatory Affairs, and Manufacturing teams. The ideal candidate should have a proven track record of developing, implementing, and transferring QC-suitable analytical testing methods that are compliant with regulatory requirements. This is a full-time position reporting to the Associate Director, Analytical Development and is located at our corporate headquarters in San Diego, California. Primary

• Serve as subject matter expert in selection and development of robust test methods to evaluate
functional activity of iNK and/or iT cells for oncology indications and in one or more of the
following techniques: flow cytometry, cellular imaging, immunoassays, or qPCR.
• Maintain knowledge of and critically evaluate scientific literature and industry trends in order to
contribute maximally to Fate's analytical development efforts.
• Evaluate and develop fit-for-use analytical test methods for the measurement of functional
activity and quality of cell therapy products.
• Design, execute, and document method development and qualification activities.
• Perform previously established methods in support of process development, product release
and stability, and product characterization needs.
• Perform data analysis and data trending to track assay performance.
• Manage assay transfer to the QC team and external partners.
• Draft and review relevant regulatory write-ups for newly-developed methods.
• Coordinate activities within a collaborative work environment across key groups to support
method development as well as the characterization of Fate's products.
• Provide mentorship and support to other teams developing analytical methods, as a technical
• Follow good documentation and review practices, and effectively communicate scientific results
and strategies in presentations and written reports.
• Draft technical reports, standard operating procedures, and test protocols in support of
analytical development.
• Ph.D. in Biological Sciences or other related field and 5+ years of experience of experience in a
biopharmaceutical organization
• Proven successful development of fit-for-use analytical methods, preferably for cell therapy
• Requires a strong background in bioanalytical development, as well as a knowledge of cGMPs,
ICH, and relevant FDA guidelines and experience in writing relevant regulatory submissions
• Excellent interpersonal, verbal and written communication skills
• Well-versed in various techniques such as aseptic cell culture, relative potency determination,
ELISA, qPCR, ddPCR, cell counting, and other applicable methods
• Comfortable in a fast-paced small company environment with minimal direction and able to
adjust workload based upon changing priorities
• Expertise in stem cell biology, immunology and/or cancer biology is strongly preferred

Working Conditions and Physical Requirements
• 100% on-site work at corporate headquarters in San Diego, CA
• Occasional evening and weekend work will be required
The preceding job description indicates the general nature and level of work performed by employees within this classification. Additional and incidental duties related to the primary duties may be required from time to time. For consideration send cover letter and resume to: and reference job code 452AB.

About Fate Therapeutics, Inc.
Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders. The Company has established a leadership position in the clinical development and manufacture of universal, off-the-shelf cell products using its proprietary induced pluripotent stem cell (iPSC) product platform. The Company's immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs). The Company's immuno-regulatory product candidates include ProTmune™, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA. For more information, please visit